Watch Lindsey Cerkovnik and Jessica Wilkerson discuss federal defenders as part of the Cybersecurity Summit 2021 Day Two presentations. This video is a recording of the livestream held on Wednesday, October 13, 2021.
The National Cybersecurity Summit is an annual event that brings together cybersecurity and critical infrastructure stakeholders from around the world to hold meaningful conversations and collaborate on how we can protect our physical and cyber infrastructure.
About the Speakers
Lindsey Cerkovnic, Federal Lead for Industrial Control Systems Vulnerability Disclosure, Cybersecurity and Infrastructure Security Agency (CISA)
Lindsey Cerkovnik is CISA's Industrial Control Systems (ICS) Vulnerability Disclosure Lead. In this role, Lindsey leads a team of control systems vulnerability analysts and subject matter experts to conduct coordinated vulnerability disclosure (CVD) with security researchers and vendors. Together with government and industry partners, Lindsey's team works to reduce risk to the Nation’s critical infrastructure by coordinating the remediation and public disclosure of newly identified cybersecurity vulnerabilities affecting ICS, Internet of Things (IoT), and medical devices.
Before joining CISA, Lindsey served as the Cyber Counterintelligence Officer for the Department of Energy's Idaho National Laboratory (INL), where she focused primarily on cyber threat analysis and digital forensics in support of national security investigations. She also conducted intelligence analysis and R&D related to control systems cybersecurity, energy infrastructure supply chains, and ICS vulnerability discovery.
She holds a M.S. in Computer and Information Sciences from the University of South Alabama and a B.A. in English Literature from Texas A&M University.
Jessica Wilkerson, Senior Cyber Policy Advisor, Food and Drug Administration (FDA)
Jessica Wilkerson is a Senior Cyber Policy Advisor with the All Hazards Readiness, Response, and Cybersecurity (ARC) team in the Center for Devices and Radiological Health (CDRH) within the Food and Drug Administration (FDA). As part of ARC, she examines issues and develops policy related to the safety and effectiveness of connected medical devices. She received a B.A. in Policy Studies and minors in Computer Science and Mathematics from Syracuse University, and a J.D. from the Catholic University of America's Columbus School of Law.